1.Peripheral ossifying fibroma arising from the maxillary bucco-palatal gingiva in an elderly male patient: a rare case report
Seo-Yeong AN ; Chan Min KIM ; Chi Heon SUNG ; Chul-Hwan KIM
Journal of the Korean Association of Oral and Maxillofacial Surgeons 2024;50(5):292-296
Peripheral ossifying fibroma (POF) is a benign tumor characterized by dystrophic calcification or ossification within the gingiva, primarily affecting the anterior maxilla of females and young adults. Its pathogenesis is unclear but linked to local irritants such as trauma, biofilm, dental calculus, and poorly fitting prostheses. In this study, a 63-year-old male presented at Dankook University Dental Hospital with a large nodular lesion on the left maxillary bucco-palatal gingiva. Preoperative imaging, including panoramic radiography and cone-beam computed tomography, was performed. Surgical excision and histological examination confirmed POF with specific morphological characteristics, including mineralized tissue with varied deposition patterns, mature and immature bone, cementum-like tissue, and dystrophic calcification. In conclusion, POF is a rare oral tumor, more common in younger females, typically presenting asymptomatically on the anterior maxilla. Histopathological analysis is crucial for diagnosis. Standard treatment involves conservative local resection, but recurrence rates range from 8% to 20%, necessitating continuous follow-up. This report aims to enhance understanding of POF by presenting a rare case of a large POF in the maxillary posterior bucco-palatal gingiva of an elderly male.
2.Peripheral ossifying fibroma arising from the maxillary bucco-palatal gingiva in an elderly male patient: a rare case report
Seo-Yeong AN ; Chan Min KIM ; Chi Heon SUNG ; Chul-Hwan KIM
Journal of the Korean Association of Oral and Maxillofacial Surgeons 2024;50(5):292-296
Peripheral ossifying fibroma (POF) is a benign tumor characterized by dystrophic calcification or ossification within the gingiva, primarily affecting the anterior maxilla of females and young adults. Its pathogenesis is unclear but linked to local irritants such as trauma, biofilm, dental calculus, and poorly fitting prostheses. In this study, a 63-year-old male presented at Dankook University Dental Hospital with a large nodular lesion on the left maxillary bucco-palatal gingiva. Preoperative imaging, including panoramic radiography and cone-beam computed tomography, was performed. Surgical excision and histological examination confirmed POF with specific morphological characteristics, including mineralized tissue with varied deposition patterns, mature and immature bone, cementum-like tissue, and dystrophic calcification. In conclusion, POF is a rare oral tumor, more common in younger females, typically presenting asymptomatically on the anterior maxilla. Histopathological analysis is crucial for diagnosis. Standard treatment involves conservative local resection, but recurrence rates range from 8% to 20%, necessitating continuous follow-up. This report aims to enhance understanding of POF by presenting a rare case of a large POF in the maxillary posterior bucco-palatal gingiva of an elderly male.
3.Peripheral ossifying fibroma arising from the maxillary bucco-palatal gingiva in an elderly male patient: a rare case report
Seo-Yeong AN ; Chan Min KIM ; Chi Heon SUNG ; Chul-Hwan KIM
Journal of the Korean Association of Oral and Maxillofacial Surgeons 2024;50(5):292-296
Peripheral ossifying fibroma (POF) is a benign tumor characterized by dystrophic calcification or ossification within the gingiva, primarily affecting the anterior maxilla of females and young adults. Its pathogenesis is unclear but linked to local irritants such as trauma, biofilm, dental calculus, and poorly fitting prostheses. In this study, a 63-year-old male presented at Dankook University Dental Hospital with a large nodular lesion on the left maxillary bucco-palatal gingiva. Preoperative imaging, including panoramic radiography and cone-beam computed tomography, was performed. Surgical excision and histological examination confirmed POF with specific morphological characteristics, including mineralized tissue with varied deposition patterns, mature and immature bone, cementum-like tissue, and dystrophic calcification. In conclusion, POF is a rare oral tumor, more common in younger females, typically presenting asymptomatically on the anterior maxilla. Histopathological analysis is crucial for diagnosis. Standard treatment involves conservative local resection, but recurrence rates range from 8% to 20%, necessitating continuous follow-up. This report aims to enhance understanding of POF by presenting a rare case of a large POF in the maxillary posterior bucco-palatal gingiva of an elderly male.
4.Bacterial Pathogens of Ventilator Associated Pneumonia in a Tertiary Referral Hospital.
Su Young CHI ; Tae Ok KIM ; Chan Woo PARK ; Jin Yeong YU ; Boram LEE ; Ho Sung LEE ; Yu Il KIM ; Sung Chul LIM ; Yong Soo KWON
Tuberculosis and Respiratory Diseases 2012;73(1):32-37
BACKGROUND: This study evaluates the bacterial pathogens of Ventilator-associated pneumonia (VAP) in a tertiary referral hospital. METHODS: A total of 109 bacterial pathogens from 91 adult patients with VAP, who were admitted to the medical intensive care unit from January 2008 to December 2009, were examined. Clinical characteristics, bacterial pathogens, and resistance profiles were analyzed. RESULTS: Staphylococcus aureus (44%) was the most frequently isolated. Acinetobacter baumanii (30%), Pseudomonas aeruginosa (12%), Stenotrophomonas maltophilia (7%), Klebsiella pneumoniae (6%), and Serratia marcescens (2%) were isolated from the transtracheal aspirates or bronchoalveolar lavage in patients with VAP. There was no significant difference of bacterial pathogens between early and late onset VAP. All isolated S. aureus were methicillin resistant S. aureus; the imipenem resistance rate of A. baumanii was 69%. CONCLUSION: The two most frequent pathogens of VAP were S. aureus and A. baumanii. There were no pathogenic differences between early and late onset VAP.
Acinetobacter
;
Adult
;
Bronchoalveolar Lavage
;
Humans
;
Imipenem
;
Intensive Care Units
;
Klebsiella pneumoniae
;
Methicillin Resistance
;
Pneumonia, Ventilator-Associated
;
Pseudomonas aeruginosa
;
Referral and Consultation
;
Serratia marcescens
;
Staphylococcus aureus
;
Stenotrophomonas maltophilia
;
Tertiary Care Centers
;
Ventilators, Mechanical
5.Bacterial Pathogens of Ventilator Associated Pneumonia in a Tertiary Referral Hospital.
Su Young CHI ; Tae Ok KIM ; Chan Woo PARK ; Jin Yeong YU ; Boram LEE ; Ho Sung LEE ; Yu Il KIM ; Sung Chul LIM ; Yong Soo KWON
Tuberculosis and Respiratory Diseases 2012;73(1):32-37
BACKGROUND: This study evaluates the bacterial pathogens of Ventilator-associated pneumonia (VAP) in a tertiary referral hospital. METHODS: A total of 109 bacterial pathogens from 91 adult patients with VAP, who were admitted to the medical intensive care unit from January 2008 to December 2009, were examined. Clinical characteristics, bacterial pathogens, and resistance profiles were analyzed. RESULTS: Staphylococcus aureus (44%) was the most frequently isolated. Acinetobacter baumanii (30%), Pseudomonas aeruginosa (12%), Stenotrophomonas maltophilia (7%), Klebsiella pneumoniae (6%), and Serratia marcescens (2%) were isolated from the transtracheal aspirates or bronchoalveolar lavage in patients with VAP. There was no significant difference of bacterial pathogens between early and late onset VAP. All isolated S. aureus were methicillin resistant S. aureus; the imipenem resistance rate of A. baumanii was 69%. CONCLUSION: The two most frequent pathogens of VAP were S. aureus and A. baumanii. There were no pathogenic differences between early and late onset VAP.
Acinetobacter
;
Adult
;
Bronchoalveolar Lavage
;
Humans
;
Imipenem
;
Intensive Care Units
;
Klebsiella pneumoniae
;
Methicillin Resistance
;
Pneumonia, Ventilator-Associated
;
Pseudomonas aeruginosa
;
Referral and Consultation
;
Serratia marcescens
;
Staphylococcus aureus
;
Stenotrophomonas maltophilia
;
Tertiary Care Centers
;
Ventilators, Mechanical
6.No Association of CYP2D6*4 and CYP2D6*10 Polymorphisms with Tardive Dyskinesia in Korean Schizophrenics.
Sung Il WOO ; Dong Woo KANG ; Han Gil SEO ; Bong Jo KIM ; In Sang LEE ; Geun Hoa JEONG ; So Young PARK ; Chi Yeong JUNG ; Hwan Cheol LEE ; Kyeong Cheon JEONG ; Jin Wook SOHN
Journal of the Korean Society of Biological Psychiatry 2000;7(2):140-146
P450 CYP2D6 enzyme(debrisoquine hydroxylase) is known to metabolize many neuroleptics and some genetic polymorphisms in the CYP2D6 gene were reported to be associated with tardive dyskinesia(TD). We investigeted the association of two genetic polymorphisms in the CYP2D6 gene, CYP2D6*4 and CYP2D6*10, with TD in Korean schizophrenic subjects. Subjects consisted of 71 Korean schizophrenics and TD was evaluated using the Abnormal Involuntary Movement Scale(AIMS). There were no statistically significant differences in the demographic variables of age, male to female percentage and the current antipsychotic(CPZ equivalent) dose between the grup with TD and the group without TD. But the duration of antipsychotic drug exposure was siginificantly higher in the group without TD(p=0.000, by independent t-test). The mean AIMS score in the group with TD was 11.2+/-6.6(S.D.). Genotypings ofr the presence of CYP2D6*4 and CYP2D6*10 wee done using PCR amplifications and endonuclease digestions. There were no statistically significant genotypic and alleleic associations between TD and CYP2D6*4(by chi-square tests), and between TD and CYP2D6*10(by chi-square tests). These results indicate that the CYP2D6*4 and CYP2D6*10 polymorphisms have no significant roles in the causation of TD.
Antipsychotic Agents
;
Asian Continental Ancestry Group
;
Cytochrome P-450 CYP2D6
;
Dyskinesias
;
Female
;
Humans
;
Male
;
Movement Disorders*
;
Polymerase Chain Reaction
;
Polymorphism, Genetic
7.Are Vitamin Beverages Good for Dental Health?
A-Reum KANG ; Su-Hee PARK ; Jung-Woong WOO ; Da-Jung HONG ; Kyu-Ri KIM ; Chi-Yeong SUNG ; Ji-Yeon WOO ; Ju-Hui JEONG ; Eun-Ha JUNG
Journal of Dental Hygiene Science 2020;20(1):9-15
Background:
Although the consumption of vitamin beverages has increased because of the recent interest in health and beauty, guidelines addressing appropriate consumption habits are lacking. Thus, the aim of this study was to investigate the erosive potential of several vitamin beverages and to propose guidelines for the appropriate intake of these drinks.
Methods:
Five vitamin beverages were selected after a pre-investigation of the current beverage market. Coca-Cola and mineral water were selected as the control beverages. The pH of the beverages was measured with a calibrated pH meter, and the titratable acidity (TA) was determined by using 1 M sodium hydroxide to reach pH 5.5 (TA5.5) and 7.0 (TA7.0). The screening method suggested by the International Organization for Standardization was used to measure pH variation (pH) by using an under-saturated hydroxyapatite solution to determine the difference between the initial and final pH of the screening solution. All measurements were performed in triplicate.
Results:
All vitamin beverages tested in this study exhibited a low pH (2.53∼2.99), similar to Coca-Cola, which is known to be a highly acidic beverage. The highest TA5.5 and TA7.0 values of the vitamin beverages were 7.03 ml and 8.81 ml, respectively. The largest change in pH determined by using the screening solution was found in Bacchus D (pH 1.44±0.05). The mean pH of the vitamin beverages was 1.12±0.29, which was higher than that of Coca-Cola (positive control, pH 0.58±0.05).
Conclusion
Vitamin beverages exhibited an erosive potential capable of damaging enamel surfaces. Therefore, the frequency of vitamin beverage intake should be limited, and individuals consuming these drinks should try to restore normal oral pH as quickly as possible.
8.Influence of Diaphragmatic Mobility on Hypercapnia in Patients with Chronic Obstructive Pulmonary Disease.
Hyun Wook KANG ; Tae Ok KIM ; Bo Ram LEE ; Jin Yeong YU ; Su Young CHI ; Hee Jung BAN ; In Jae OH ; Kyu Sik KIM ; Yong Soo KWON ; Yu Il KIM ; Young Chul KIM ; Sung Chul LIM
Journal of Korean Medical Science 2011;26(9):1209-1213
A reduction in diaphragm mobility has been identified in patients with chronic obstructive pulmonary disease (COPD) and has been associated with a decline in pulmonary function parameters. However, little information exists regarding the potential role of diaphragm mobility on hypercapnia in COPD. A new method of assessing the mobility of the diaphragm, using ultrasound, has recently been validated. The purpose of the present study was to investigate the relationship between diaphragm mobility and pulmonary function parameters, as well as that between arterial blood gas values and diaphragm mobility, in COPD patients. Thirty seven COPD patients were recruited for pulmonary function test, arterial blood gas analysis and diaphragm mobility using ultrasound to measure the craniocaudal displacement of the left branch of the portal vein. There were significant negative correlations between diaphragmatic mobility and PaCO2 (r = -0.373, P = 0.030). Diaphragmatic mobility correlated with airway obstruction (FEV1, r = 0.415, P = 0.011) and with ventilatory capacity (FVC, r = 0.302, P = 0.029; MVV, r = 0.481, P = 0.003). Diaphragmatic mobility also correlated significantly with pulmonary hyperinflation. No relationship was observed between diaphragm mobility and PaO2 (r = -0.028, P = 0.873). These findings support a possibility that the reduction in diaphragm mobility relates to hypercapnia in COPD patients.
Aged
;
Airway Resistance/physiology
;
Carbon Dioxide/blood/physiology
;
Diaphragm/physiopathology/*ultrasonography
;
Female
;
Humans
;
Hypercapnia/complications/*physiopathology
;
Male
;
Middle Aged
;
Portal Vein
;
Pulmonary Disease, Chronic Obstructive/complications/*physiopathology/ultrasonography
;
Pulmonary Gas Exchange
;
Respiratory Muscles/physiopathology
9.Prognostic Value of Vascular Endothelial Growth Factor (VEGF) and Basic Fibroblast Growth Factor (bFGF) Expression in Resected Non-small Cell Lung Cancer.
Seung Joon KIM ; Jung Mi LEE ; Jin Sook KIM ; Ji Young KANG ; Sang Hak LEE ; Seok Chan KIM ; Sook Young LEE ; Chi Hong KIM ; Joong Hyun AHN ; Soon Seog KWON ; Young Kyoon KIM ; Kwan Hyoung KIM ; Hwa Sik MOON ; Jeong Sup SONG ; Sung Hak PARK ; Seok Hwan MOON ; Yeong Pil WANG
Tuberculosis and Respiratory Diseases 2008;64(3):200-205
BACKGROUND: Tumor angiogenesis plays an important role in tumor growth, maintenance and metastatic potential. Tumor tissue produces many types of angiogenic growth factors. Vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) have both been implicated to have roles in tumor angiogenesis. In this study, the expression of tissue VEGF and bFGF from non-small cell lung cancer (NSCLC) patients were analyzed. METHODS: We retrospectively investigated 35 patients with a histologically confirmed adenocarcinoma or squamous cell carcinoma of the lung, where the primary curative approach was surgery. An ELISA was employed to determine the expression of VEGF and bFGF in extracts prepared from 35 frozen tissue samples taken from the cancer patients. RESULTS: VEGF and bFGF concentrations were significantly increased in lung cancer tissue as compared with control (non-cancerous) tissue. The VEGF concentration was significantly increased in T2 and T3 cancers as compared with T1 cancer. Expression of VEGF was increased in node-positive lung cancer tissue as compared with node-negative lung cancer tissue (p=0.06). VEGF and bFGF expression were not directly related to the stage of lung cancer and patient survival. CONCLUSION: Expression of VEGF and bFGF were increased in lung cancer tissue, and the expression of VEGF concentration in lung cancer tissue was more likely related with tumor size and the presence of a lymph node metastasis than the expression of bFGF. However, in this study, expression of both VEGF and bFGF in tissue were not associated with patient prognosis.
Adenocarcinoma
;
Carcinoma, Non-Small-Cell Lung
;
Carcinoma, Squamous Cell
;
Enzyme-Linked Immunosorbent Assay
;
Fibroblast Growth Factor 2
;
Humans
;
Intercellular Signaling Peptides and Proteins
;
Lung
;
Lung Neoplasms
;
Lymph Nodes
;
Neoplasm Metastasis
;
Prognosis
;
Retrospective Studies
;
Vascular Endothelial Growth Factor A
10.A Retrospective Analysis for Patients with HER2-Positive Gastric Cancer Who Were Treated with Trastuzumab-Based Chemotherapy: In the Perspectives of Ethnicity and Histology.
Jun Ho YI ; Jung Hun KANG ; In Gyu HWANG ; Hee Kyung AHN ; Hyun Jin BAEK ; Soon Il LEE ; Do Hyoung LIM ; Young Woong WON ; Jun Ho JI ; Hyo Song KIM ; Sun Young RHA ; Sung Yong OH ; Kyung Eun LEE ; Taekyu LIM ; Chi Hoon MAENG ; Moon Jin KIM ; Seung Tae KIM ; Jeeyun LEE ; Joon Oh PARK ; Young Suk PARK ; Ho Yeong LIM ; Won Ki KANG ; Se Hoon PARK
Cancer Research and Treatment 2016;48(2):553-560
PURPOSE: While the Trastuzumab for Gastric Cancer (ToGA) trial demonstrated the efficacy and safety of trastuzumab-based chemotherapy in HER2-positive metastatic gastric cancer, the overall survival (OS) benefit was not found in Asian and diffuse-type cancer patients. The aim of the study is to investigate predictive markers for trastuzumab-based chemotherapy. MATERIALS AND METHODS: Data of patients with HER2-positive gastric cancer treated with trastuzumab-based chemotherapy were analyzed retrospectively. RESULTS: A total of 168 Asian patients were included. The median age was 60 years (range, 27 to 85 years) and the male:female ratio was 118 (70.2%):50 (29.8%). Fourteen (8.3%), 63 (37.5%), 75 (44.6%), and 11 (6.5%) patients had well, moderately, poorly-differentiated tubular adenocarcinoma and signet ring cell carcinoma, respectively. With 14 complete responses and 73 partial responses, the response rate was 50.6%. The median progression-free survival (PFS) was 10.2 months (95% confidence interval [CI], 8.7 to 11.7), and the median OS was 18.5 months (95% CI, 16.4 to 50.6). Next, we investigated the effect of poorly-differentiated histology (PDH, poorly-differentiated tubular adenocarcinoma+signet ring cell carcinoma) on clinical outcomes. The median PFS (8.9 months vs. 11.5 months, p=0.16) was slightly inferior in PDH patients, and the median OS was significantly shorter in PDH patients (14.6 months vs. 19.0 months, p=0.025). CONCLUSION: While subset analysis of the ToGA trial demonstrated that trastuzumab-based chemotherapy may not be beneficial for Asians and patients with PDH, our data may suggest that even in Asian patients and patients with PDH, trastuzumab-based chemotherapy could be associated with improved clinical outcomes in patients with HER2-positive gastric cancer.
Adenocarcinoma
;
Asian Continental Ancestry Group
;
Carcinoma, Signet Ring Cell
;
Disease-Free Survival
;
Drug Therapy*
;
Ethnic Groups
;
Humans
;
Receptor, erbB-2
;
Retrospective Studies*
;
Stomach Neoplasms*